Invitrogen™ ELISA Kit for Human IL-28A

Ref.: BL-RE-090908Manufacturer ref.: EHIL28AX10 10 x 96 tests
€4,815.00 excl. VAT

The family of lambdas of the IFN, a new family of cytokines within the IL-10 superfamily, belongs to L-Il-28A. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2) and IL-28B (IFN lambda 3), and are also...

Accession number
Q8IZJ0
Dose range
13.72 to 10.000 pg/ml
Sensitivity of the dosage
15 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

The family of lambdas of the IFN, a new family of cytokines within the IL-10 superfamily, belongs to L-Il-28A. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2) and IL-28B (IFN lambda 3), and are also...

The family of lambdas of the IFN, a new family of cytokines within the IL-10 superfamily, belongs to L-Il-28A. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2) and IL-28B (IFN lambda 3), and are also known as III interferons. The lambda IFNs are reported by a heterodimer receptor, one of which, IL-10R2, is shared with other members of the superfamily. The second subunit, IFN lambda R1 or IL-28R alpha, is unique to the lambda IFN. Signalling occurs through the Jak / STAT pathway in the same way as type I IFN (IFN alpha / beta) and activates several of the same genes despite a low sequence homology between cytokines and receptors in both families. Both families of d的IFN have antiviral activity through the induction of antiviral protein production in target cells and the regulation of class I expression in MHC. These proteins also have anti-proliferative and anti-tumour effects, making them a possible alternative to the therapies for alpha-IFN cancer. Unlike Type I IFN, which can stimulate most cells, the response to stimulation of the lambda IFN appears to be limited to dendritic and certain tumour cells due to the limited expression of the IFN lambda R1. Another notable difference is the ability of the stimulation of the lambda IFN cells to drive the dendritic cells towards the production of regulatory CD4+CD25+FoxP3+ T cells, suggesting a possible immunoregulatory role

Sensitivity

Sensitivity of dosage: 15 pg/ml.

Measurement range

Dose range: 13.72 to 10.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: IL-28 A.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17777953
Specifications
Accession numberQ8IZJ0
Dose range13.72 to 10.000 pg/ml
Sensitivity of the dosage15 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)282616
Gene symbol(s)IFNL2
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetIL-28 A
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Serum, 50 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHIL28AX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.